Axel Norwitch

Axel Norwitch is a corporate M&A lawyer with a focus on strategic cross-border transactions.

He advises both Dutch and international clients—ranging from fast-scaling tech ventures to listed multinationals—on complex mergers, acquisitions, and joint ventures. Axel has built a strong track record in sectors including life sciences, fintech, logistics, and industrial manufacturing.

He is known for his calm under pressure, commercial pragmatism, and ability to navigate sensitive stakeholder dynamics. Axel is a core member of the firm’s Corporate Transactions team and is frequently brought in on high-stakes deals requiring discreet, solution-driven execution.

Axel has been recognised as a “Next Generation Partner” in Corporate M&A by Legal500.

Axel’s recent work includes advising:

• Borealis Ventures on the cross-border acquisition of MedixGroup in Germany and the Netherlands

• Lydian Capital on the carve-out of its logistics division to a US-based private equity firm

• SynCor Pharma on its strategic merger with Lifegenics, creating one of Europe’s largest biopharma groups

• A European family office on a joint venture with a listed real estate developer for a €500M urban regeneration project

• Finovia on its acquisition of three cloud-based accounting SaaS providers across the Benelux

• Axovent Capital on the sale of its minority stake in BlueCargo to Maersk Ventures

• Halion Group on the acquisition of multiple renewable energy assets in Southern Europe

• Deltora Industrial on the divestment of its chemicals unit to a Chinese strategic buyer

• A Dutch listed company on its internal restructuring ahead of a dual listing in Frankfurt

• Quantex on a cross-border share swap with a Scandinavian IoT developer